Alcista
$128.92
Precio del escenario
$120.510
-2.699 (-2.24%)Al cierre
Aflac Incorporated provides financial protection to policyholders and customers through its subsidiaries in the United States and Japan. The Company's principal business is supplemental health and life insurance products. Its segments include Aflac Japan, which includes Aflac Life Insurance Japan Ltd. (ALIJ), and Aflac U.S., which includes American Family Life Assurance Company of Columbus (Aflac), American Family Life Assurance Company of New York (Aflac New York), Continental American Insurance Company (CAIC), Tier One Insurance Company (TOIC), and Aflac Benefits Solutions, Inc. (ABS). The Aflac Japan segment is the insurer in Japan in terms of cancer and medical (third sector insurance products) policies in force. The Company designs its United States insurance products to provide supplemental coverage for people who already have major medical or primary insurance coverage, as Aflac U.S. insurance policies pay benefits regardless of other insurance.
Aflac Inc is a good buy right now due to its current price of $120.51, which is below the analyst price target of $133 from BofA, indicating potential upside of 10.5%. Additionally, the stock has shown a solid year-to-date change of +9.32% and a 1-year change of +12.05%, reflecting strong performance. However, the main risk is the forward P/E ratio of 15.20, which suggests that the stock may be overvalued if earnings do not meet expectations in the upcoming quarters.
BofA
$133
2026-10-12
BofA
2026-10-12
Precio objetivo
$133
Mizuho
$107
2026-10-07
Mizuho
2026-10-07
Precio objetivo
$107
Barclays
$101
2026-10-07
Barclays
2026-10-07
Precio objetivo
$101
UBS
$125
2026-10-06
UBS
2026-10-06
Precio objetivo
$125
Wells Fargo
$122
2026-08-19
Wells Fargo
2026-08-19
Precio objetivo
$122
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

Aflac Study Reveals Legacy Planning Gaps for U.S. Workforce

Aflac Study Reveals Legacy Planning Gaps for U.S. Workforce

Brian Jordan Brings Hope to Children with Cancer

Brian Jordan Brings Hope to Children with Cancer

Aflac and Rachel Zoe Launch Cancer Screening Jacket
Aflac Incorporated provides financial protection to policyholders and customers through its subsidiaries in the United States and Japan. The Company's principal business is supplemental health and life insurance products. Its segments include Aflac Japan, which includes Aflac Life Insurance Japan Ltd. (ALIJ), and Aflac U.S., which includes American Family Life Assurance Company of Columbus (Aflac), American Family Life Assurance Company of New York (Aflac New York), Continental American Insurance Company (CAIC), Tier One Insurance Company (TOIC), and Aflac Benefits Solutions, Inc. (ABS). The Aflac Japan segment is the insurer in Japan in terms of cancer and medical (third sector insurance products) policies in force. The Company designs its United States insurance products to provide supplemental coverage for people who already have major medical or primary insurance coverage, as Aflac U.S. insurance policies pay benefits regardless of other insurance. It operates in the Financials sector (ACCIDENT & HEALTH INSURANCE industry).
Aflac Inc is a good buy right now due to its current price of $120.51, which is below the analyst price target of $133 from BofA, indicating potential upside of 10.5%. Additionally, the stock has shown a solid year-to-date change of +9.32% and a 1-year change of +12.05%, reflecting strong performance. However, the main risk is the forward P/E ratio of 15.20, which suggests that the stock may be overvalued if earnings do not meet expectations in the upcoming quarters.
15 analysts cover AFL: 3 rate it Buy, 10 Hold and 2 Sell. The average price target is 110.90.
Aún no hay publicaciones
Regístrate o inicia sesión para participarEsta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.